Picture of Atomo Diagnostics logo

AT1 — Atomo Diagnostics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Atomo Diagnostics Says Access Bio Receives FDA Clearance For Covid-19 Antibody Test

June 28 (Reuters) - Atomo Diagnostics Ltd  AT1.AX :
    * ACCESS BIO RECEIVES FDA CLEARANCE FOR COVID-19 ANTIBODY
TEST
    * CO, ACCESS BIO ARE IN TALKS FOR THEIR COVID-19 RAPID TEST
COMMERCIAL ARRANGEMENTS

Source text for Eikon:  ID:nASX7xQFsc 
Further company coverage:  AT1.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Atomo Diagnostics

See all news